Psychopharmacological Management of Bruxism in Children
Direct Recommendation
There is no evidence-based psychopharmacological treatment recommended for bruxism in children, and conservative non-pharmacological approaches should be prioritized. 1, 2
Evidence Base and Clinical Approach
Current State of Evidence
- No established pharmacological treatment exists for pediatric bruxism, and management should focus on identifying and addressing underlying conditions rather than prescribing medications 1
- The limited research on medications (hydroxyzine, trazodone, flurazepam) shows some reduction in self-reported bruxism and associated headaches, but these studies lack the rigor needed to support routine clinical use 2
- Bruxism should not be considered a disorder requiring treatment in otherwise healthy children, but rather a behavior that may signal underlying psychosocial or sleep disturbances 3, 2
Recommended Management Strategy
Step 1: Comprehensive Assessment
- Identify underlying factors including sleep disturbances, anxiety levels, psychosocial stressors, and parafunctional habits, as these are the most strongly associated factors with pediatric bruxism 1
- Rule out secondary causes such as medications (particularly psychotropic medications that may induce bruxism as a side effect) or medical conditions 4
- Assess for temporomandibular disorders, headaches, and behavioral/sleep disorders that commonly accompany bruxism 1
Step 2: Non-Pharmacological Interventions (First-Line)
- Psychological techniques including directed muscular relaxation and stress management have demonstrated effectiveness in reducing anxiety levels and temporomandibular joint disorders in children with bruxism (P < 0.05) 5
- Counseling regarding sleep hygiene, sleep habit modification, and relaxation techniques should be implemented as the initial therapeutic intervention 4
- Physical therapy interventions have shown reduction in self-reported bruxism and associated symptoms 2
Step 3: When to Consider Pharmacological Consultation
- If bruxism is associated with a diagnosed psychiatric disorder (anxiety, ADHD, depression), treatment should target the underlying psychiatric condition following AACAP guidelines for comprehensive psychiatric and medical evaluation before initiating any psychotropic medication 6
- Any psychotropic medication use must follow rigorous principles: complete psychiatric evaluation, develop treatment and monitoring plan, obtain informed consent/assent, and conduct adequate medication trials with clear target symptoms 6
Critical Caveats
Avoid These Common Pitfalls:
- Do not prescribe psychotropic medications specifically for bruxism in the absence of a diagnosed psychiatric disorder, as this represents inappropriate medication use 6, 1
- Be aware that some psychotropic medications can cause or worsen bruxism (particularly SSRIs and stimulants), so medication review is essential if bruxism develops or worsens during psychiatric treatment 4
- Do not use benzodiazepines routinely despite case reports of clonazepam for sleep bruxism in adults, as the evidence is insufficient and the risks in children (dependence, cognitive effects) outweigh potential benefits 4
Special Considerations
- Bruxism in children may serve as a warning sign of psychological disorders and should prompt evaluation for anxiety, stress, or other emotional difficulties 3
- The biopsychosocial model should guide assessment, with particular attention to sleep quality, personality traits, stress levels, and headaches 1
- Parental or caregiver reports of teeth grinding remain the most reliable diagnostic tool and should be accompanied by thorough clinical examination 1
When Psychiatric Medication Is Necessary for Comorbid Conditions
If a child with bruxism requires psychotropic medication for a separate psychiatric disorder:
- Follow AACAP principles requiring comprehensive evaluation before medication initiation 6
- Monitor for medication-induced or worsened bruxism as a side effect 4
- Reassess if bruxism worsens, as this may indicate the need for medication adjustment rather than adding another medication 6
- Avoid polypharmacy unless there is clear rationale for treating multiple distinct disorders 6